Glycerol Phenylbutyrate
CAS 611168-24-2
Glycerol phenylbutyrate turns three phenylbutyrate units into a prodrug designed to create an alternative route for nitrogen disposal.
Glycerol Phenylbutyrate (CAS 611168-24-2) shows how molecular structure determines chemical role. Glycerol phenylbutyrate (CAS 611168-24-2) is a nitrogen-scavenging medicine developed for chronic management of urea cycle disorders. It is a triglyceride-like molecule in which glycerol is esterified with three molecules of phenylbutyric acid. After oral administration, digestive lipases release phenylbutyrate, which is converted to phenylacetate. Phenylacetate then conjugates with glutamine to form phenylacetylglutamine, providing an alternative route for nitrogen excretion in urine when the urea cycle cannot handle nitrogen normally. The FDA-approved product RAVICTI is an oral liquid containing glycerol phenylbutyrate and entered U.S. marketing in 2013. The prodrug design is chemically important: packaging three phenylbutyrate units on glycerol changes delivery while preserving the nitrogen-disposal chemistry of phenylacetate downstream.
Published:
2026-10-01